Click to edit position descriptionAccerax is a Custom Cycling Wear solutions provider. We design, print and manufacture Cycling Jerseys, Tights, Bib-Shorts, Tri-Suits, Cycling Caps, Arm-Covers, Technical Tees and provide team/event consultation for our customer's racing and branding needs.
Some of our clients:
- DBS Vickers Securities
- Habitat for Humanity
- ABN Amro
- Rajah & Tann
- TripAdvisor
- University of Iowa
- SMU
Some of our clients:
- DBS Vickers Securities
- Habitat for Humanity
- ABN Amro
- Rajah & Tann
- TripAdvisor
- University of Iowa
- SMU
Employees: 51-200
Founded date: 2012
Investors 1
| Date | Name | Website |
| - | Inventages | inventages... |
Mentions in press and media 6
| Date | Title | Description |
| 28.02.2017 | Thumped by the FDA, Accera’s attempt to do a serious Alzheimer’s PhIII ends with a flop | Accera CEO Charles Stacey A couple of years after Accera fell afoul of the FDA for its “false and misleading” label for a brain food product marketed as a treatment for Alzheimer’s, the Boulder, CO-based biotech decided to jum... |
| 30.01.2017 | The Phase 3 Alzheimer’s company few have heard of | The company had two lucky breaks, which, ironically have in some ways backfired in terms of awareness and credibility. The first is that its active compound didn’t require lengthy clinical trials. As a result, many wrote it off as an unprov... |
| 16.10.2013 | Where is the cloud comfort zone for pharma and biotech companies? | In addition to sales teams, shared databases are also helping drug developers identify principal investigators. Principal investigator contact details used to be considered proprietary information. But studies from the likes of Quintiles fo... |
| 19.07.2013 | VC Investment in Boulder-Denver Area Companies Climbs to $111M in Q2 | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Accera, a pharmaceutical developer based in Broomfield that’s developing an Alzheimer’s-fighting shake, led the pack of Colorado companies that received venture capital in the... |
| - | Where is the cloud comfort zone for pharma and biotech companies? | If any sector gets more flack for being slow to adopt innovative IT than healthcare, it’s the pharmaceutical industry. Yet, as companies have been forced to find new ways to streamline work flows and reduce costs, many are finding that some... |
| - | The Phase 3 Alzheimer’s company few have heard of | A ketone strip used to measure levels of ketone bodies in the patient’s system In a field dominated by Big Pharma and clinical trials that cost tens of millions of dollars, one small private company has made it all the way to Phase 3 trials... |